Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in North America, Europe and Israel or involving organisations from these countries.

Total search results: 7341 | Ordered by Date (descending)
1 2 3 ... 72 73 74  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
MiroBio–Advent Life Sciences: investment, 202206 financing round Series B totalling £80m incl existing + co-investor Advemt Life Sciences 2022-06-29
MiroBio–Monograph Capital: investment, 202206 financing round Series B totalling £80m incl new + co-investor Monograph Capital 2022-06-29
MiroBio–OrbiMed: investment, 202206 financing round Series B totalling £80m incl new + co-investor OrbiMed 2022-06-29
MiroBio–Samsara Biocapital: investment, 202206 financing round Series B totalling £80m incl existing + co-investor Samsara Biocapital 2022-06-29
MiroBio–SR One: investment, 202206 financing round Series B totalling £80m incl existing + co-investor SR One 2022-06-29
MiroBio–Univ Oxford: investment, 202206 financing round Series B totalling £80m incl existing + co-investor Oxford Science Enterprises 2022-06-29
Dunad Therapeutics–Ten Bridge Communications: public relations, 202206 service existent Ten Bridge is media contact 2022-06-28
Menarini–NewAmsterdam Pharma: obicetrapib, 202206– license excl €115m upfront + €27.5m funding + €863m milestones for cardiovascular in Europe 2022-06-28
Epizyme–Ipsen: investment, 202206– cash tender offer $247m + 1CVR/share ANNOUNCED 2022-06-27
Micropep Technologies–SEVERAL: investment, 202206 financing round Series A1 €8.75m led by new investor Fall Line Capital 2022-06-27
Epoch Biodesign–BoxGroup: investment, 202206c seed financing round totalling $11m incl co-investor BoxGroup 2022-06-22
Epoch Biodesign–Lowercarbon Capital: investment, 202206c seed financing round totalling $11m incl lead investor Lowercarbon Capital 2022-06-22
Epoch Biodesign–SEVERAL: investment, 202206c seed financing round $11m led by Lowercarbon Capital 2022-06-22
SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures 2022-06-22
Abound Bio–Galapagos: investment, 202206 acquisition $14m in cash of AboundBio by Galapagos 2022-06-21
CellPoint–Galapagos: investment, 202206 acquisition in cash €125m upfront + €100m milestones of CellPoint by Galapagos 2022-06-21
JnJ–Evotec: drug discovery services, 202206– collab discover novel mode of action drugs using TargetAlloMod platforms for Janssen Pharmaceutica 2022-06-14
Spirea–R42 Group: investment, 202206 financing round totalling £2.4m incl co-investor R42 Group 2022-06-14
Spirea–SEVERAL: investment, 202206 financing round £2.4m led by Jonathan Milner + Cambridge Enterprise 2022-06-14
ImCheck Therapeutics–SEVERAL: investment, 202206 financing round Series C €80m co-led by new investors Earlybird + Andera Partners 2022-06-13
Charm Therapeutics–Axial: investment, 202206 financing round Series A totalling $50m incl co-investor Axial 2022-06-09
Charm Therapeutics–Braavos Investment Advisers: investment, 202206 financing round Series A totalling $50m incl co-investor Braavos 2022-06-09
Charm Therapeutics–F-Prime: investment, 202206 financing round Series A totalling $50m incl co-lead investor F-Prime Capital 2022-06-09
Charm Therapeutics–General Catalyst: investment, 202206 financing round Series A totalling $50m incl co-investor General Catalyst 2022-06-09
Charm Therapeutics–Khosla Ventures: investment, 202206 financing round Series A totalling $50m incl co-investor Khosla Ventures 2022-06-09
Charm Therapeutics–OrbiMed: investment, 202206 financing round Series A totalling $50m incl co-lead investor OrbiMed 2022-06-09
Charm Therapeutics–SEVERAL: investment, 202206 financing round Series A $50m co-led by F-Prime Capital + OrbiMed 2022-06-09
Forbion–SEVERAL: investment, 202206 first close €470m of Forbion Growth Opportunities Fund II with target size of €600m hard cap 2022-06-09
Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners 2022-06-09
Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital 2022-06-09
Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures 2022-06-09
Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital 2022-06-09
Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine 2022-06-09
Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners 2022-06-09
Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures 2022-06-09
Relation Therapeutics–SEVERAL: investment, 202206 seed financing round $25m co-led by DCVC + Magentic Ventures 2022-06-09
Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences 2022-06-08
Frame Cancer Therapeutics–CureVac: investment, 202206 acquisition in shares €32m with €16m upfront + €16m milestones 2022-06-08
ImmunOs Therapeutics–BioMedPartners: investment, 202206 financing round Series B totalling $74m incl existing + co-investor BioMedPartners 2022-06-07
ImmunOs Therapeutics–Fiscus Financial: investment, 202206 financing round Series B totalling $74m incl new + co-investor Fiscus Financial 2022-06-07
ImmunOs Therapeutics–Gimv: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Gimv 2022-06-07
ImmunOs Therapeutics–GL Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor GL Capital 2022-06-07
ImmunOs Therapeutics–Lightspeed Venture Partners: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Lightspeed VP 2022-06-07
ImmunOs Therapeutics–Mission BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Mission BioCapital 2022-06-07
ImmunOs Therapeutics–Peak6 Strategic Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Peak6 2022-06-07
ImmunOs Therapeutics–Pfizer: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Pfizer Ventures 2022-06-07
ImmunOs Therapeutics–Samsara BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Samsara BioCapital 2022-06-07
ImmunOs Therapeutics–Schroders: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Schroder Adveq 2022-06-07
ImmunOs Therapeutics–SEVERAL: investment, 202206 financing round Series B $74m led by Samsara BioCapital + Lightspeed VP + Gimv 2022-06-07
Turning Point Therapeutics–BMS: investment, 202206– acquisition cash tender offer $4.1b at $76/share 2022-06-03
Vizgen–ARCH Venture: investment, 202206 financing round Series C totalling $85.2m incl existing + co-lead investor ARCH Venture Partners 2022-06-03
Vizgen–Blue Water Life Science Advisors: investment, 202206 financing round Series C totalling $85.2m incl co-lead investor Blue Water LSA 2022-06-03
Vizgen–Northpond Ventures: investment, 202206 financing round Series C totalling $85.2m incl existing + co-investor Northpond Ventures 2022-06-03
Vizgen–Novalis LifeSciences: investment, 202206 financing round Series C totalling $85.2m incl co-investor Novalis LifeSciences 2022-06-03
Vizgen–PERSON: investment, 202206 financing round Series C totalling $85.2m incl co-investor David Walt 2022-06-03
Vizgen–SEVERAL: investment, 202206 financing round Series C $85.2m co-led by Blue Water Life Science + ARCH Venture Partners 2022-06-03
Vizgen–Sofina: investment, 202206 financing round Series C totalling $85.2m incl co-investor Sofina 2022-06-03
Vizgen–Tao Capital: investment, 202206 financing round Series C totalling $85.2m incl co-investor Tao Capital Partners 2022-06-03
BMS–Immatics: cancer immunotherapy, 202201– collab strategic alliance expansion $60m upfront + $700 milestones per programme using ACTallo platform 2022-06-02
Transition Bio–SEVERAL: investment, 202206 financing round Series A $50m led by Northpond Ventures 2022-06-02
Watchmaker Genomics–Decheng Capital: investment, 202206 financing round Series A totalling $40m incl lead investor Decheng Capital 2022-06-02
Watchmaker Genomics–Eclipse Ventures: investment, 202206 financing round Series A totalling $40m incl co-investor Eclipse Ventures 2022-06-02
Watchmaker Genomics–SEVERAL: investment, 202206 financing round Series A $40m led by Decheng Capital 2022-06-02
Affinivax–GSK: investment, 202205– acquisition 100% for $2.1b upfront + $1.2b milestones by GSK ANNOUNCED 2022-05-31
Repertoire Genesis–Eurofins: investment, 202205 acquisition of majority stake by Eurofins Scientific 2022-05-31
Ultima Genomics–aMoon: investment, 202205 emerges from stealth with $600m incl investor aMoon 2022-05-31
Ultima Genomics–Andreessen Horowitz: investment, 202205 emerges from stealth with $600m incl investor a16z 2022-05-31
Ultima Genomics–D1 Capital: investment, 202205 emerges from stealth with $600m incl investor D1 Capital 2022-05-31
Ultima Genomics–Founders Fund: investment, 202205 emerges from stealth with $600m incl investor Founders Fund 2022-05-31
Ultima Genomics–General Atlantic: investment, 202205 emerges from stealth with $600m incl investor General Atlantic 2022-05-31
Ultima Genomics–Khosla Ventures: investment, 202205 emerges from stealth with $600m incl investor Khosla Ventures 2022-05-31
Ultima Genomics–Lightspeed Venture Partners: investment, 202205 emerges from stealth with $600m incl investor Lightspeed 2022-05-31
Ultima Genomics–PERSON: investment, 202205 emerges from stealth with $600m incl investor Marius Nacht 2022-05-31
Ultima Genomics–Playground Global: investment, 202205 emerges from stealth with $600m incl investor Playground Global 2022-05-31
Ultima Genomics–SEVERAL: investment, 202205 emerges from stealth with $600m raised from leading life science investors 2022-05-31
Advent Life Sciences–Scius Communications: public relations, 202205 supply service existent by Scius Communications 2022-05-26
ProFound Therapeutics–Flagship Pioneering: investment, 202205 Flagship unveils ProFound Tx with $75m initally committed 2022-05-26
uMotif–Athyrium Capital: investment, 202205 investment $25.5m from fund managed by Athyrium Capital Management LP 2022-05-25
Pancryos–Partners HealthCare: drug delivery technology, 202205– license ww excl from BWH for ceMED for delivery of PanINSULA 2022-05-24
Cygnal Therapeutics–Inzen Therapeutics: investment, 202205 merger of Flaghsip companies Inzen Tx + Cygnal Tx into Sonata Therapeutics 2022-05-18
SwanBio Therapeutics–Mass General Brigham Ventures: investment, 202205 financing round Series B totalling $56m incl existing + co-lead investor MGBV 2022-05-18
SwanBio Therapeutics–SEVERAL: investment, 202205 financing round Series B $56m led by founding investors Syncona Ltd + Mass General Brigham Ventures 2022-05-18
SwanBio Therapeutics–Syncona: investment, 202205 financing round Series B totalling $56m incl existing + co-lead investor Syncona Ltd 2022-05-18
Apollo Global Management–Sofinnova: life science financing, 202205– strategic partnership incl investm in Sofinnova Partners + up to $1b capital 2022-05-16
Kriya Therapeutics–Patient Square Capital: investment, 202205 financing round Series C totalling $270m incl lead investor Patient Square Capital 2022-05-16
Kriya Therapeutics–SEVERAL: investment, 202205 financing round Series C $270m led by Patient Square Capital 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– acquisition of minority equity interest in Sofinnova Partners as part of strategic partnership 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– commitment of up to $1b managed capital to Sofinnova Partners investment funds by Apollo 2022-05-16
Artax Biopharma–Advent Life Sciences: investment, 202205 financing round totalling $26m incl existing investor Advent Life Sciences 2022-05-11
Artax Biopharma–Columbus Venture Partners: investment, 202205 financing round totalling $26m incl existing investor Columbus Venture Partners 2022-05-11
Artax Biopharma–Lilly: investment, 202205 financing round totalling $26m incl new investor Eli Lilly 2022-05-11
Artax Biopharma–PERSON: investment, 202205 financing round totalling $26m incl existing investor Belinda Termeer 2022-05-11
Artax Biopharma–SEVERAL: investment, 202205 financing round $26m with new investors Eli Lilly + Sound Bioventures et al 2022-05-11
Artax Biopharma–Sound Bioventures: investment, 202205 financing round totalling $26m incl new investor Sound Bioventures 2022-05-11
Domain Therapeutics–BPCE: investment, 202205 financing round Series A totalling €39m incl existing + co-investor Seventure Partners 2022-05-10
Domain Therapeutics–Canada (govt): investment, 202205 financing round Series A totalling €39m incl co-investor adMare BioInnovations 2022-05-10
Domain Therapeutics–CTI Life Sciences: investment, 202205 financing round Series A totalling €39m incl co-lead investor CTI Life Sciences 2022-05-10
Domain Therapeutics–Helsinn: investment, 202205 financing round Series A totalling €39m incl co-lead investor 3B Future Health Fund 2022-05-10
Domain Therapeutics–Omnes Capital: investment, 202205 financing round Series A totalling €39m incl co-investor Omnes 2022-05-10
Domain Therapeutics–Panacea Venture: investment, 202205 financing round Series A totalling €39m incl co-lead investor Panacea Venture 2022-05-10
1 2 3 ... 72 73 74  next pagenext page



Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group ChinaBio Partnering Forum 2022 650x300

» top